Related references
Note: Only part of the references are listed.Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial
Farid Boulad et al.
NATURE MEDICINE (2022)
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease
Julie Kanter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease
Sunita Goyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis
Rahyssa Rodrigues Sales et al.
FRONTIERS IN PHARMACOLOGY (2022)
Targeting fetal hemoglobin expression to treat beta hemoglobinopathies
Martin H. Steinberg
EXPERT OPINION ON THERAPEUTIC TARGETS (2022)
Globin vector regulatory elements are active in early hematopoietic progenitor cells
Annalisa Cabriolu et al.
MOLECULAR THERAPY (2022)
High-level correction of the sickle mutation is amplified in vivo during erythroid differentiation
Wendy Magis et al.
ISCIENCE (2022)
Investigational curative gene therapy approaches to sickle cell diseaseY
David A. Williams et al.
BLOOD ADVANCES (2021)
Treating sickle cell anemia
John F. Tisdale et al.
SCIENCE (2020)
A Novel BaEVRless-Pseudotyped γ-Globin Lentiviral Vector Drives High and Stable Fetal Hemoglobin Expression and Improves Thalassemic Erythropoiesis In Vitro
Ekati Drakopoulou et al.
HUMAN GENE THERAPY (2019)
Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease
Stephan Menzel et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies
Constantinos C. Loucari et al.
HUMAN GENE THERAPY METHODS (2018)
An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype
Leslie Weber et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Sickle Cell Disease
Baba Inusa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Gene Therapy in a Patient with Sickle Cell Disease
Jean-Antoine Ribeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
β-Globin-Expressing Definitive Erythroid Progenitor Cells Generated from Embryonic and Induced Pluripotent Stem Cell-Derived Sacs
Atsushi Fujita et al.
STEM CELLS (2016)
Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells
Fabrizia Urbinati et al.
EXPERIMENTAL HEMATOLOGY (2015)
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs
Anais Girard-Gagnepain et al.
BLOOD (2014)
Three fingers on the switch: Kruppel-like factor 1 regulation of γ-globin to β-globin gene switching
Michael R. Tallack et al.
CURRENT OPINION IN HEMATOLOGY (2013)
Characterization and comparative performance of lentiviral vector preparations concentrated by either one-step ultrafiltration or ultracentrifugation
Eleni Papanikolaou et al.
VIRUS RESEARCH (2013)
Management of the Thalassemias
Nancy F. Olivieri et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
A novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized mice
Cecilia Frecha et al.
BLOOD (2012)
The New Self-Inactivating Lentiviral Vector for Thalassemia Gene Therapy Combining Two HPFH Activating Elements Corrects Human Thalassemic Hematopoietic Stem Cells
Eleni Papanikolaou et al.
HUMAN GENE THERAPY (2012)
Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients
Laura Breda et al.
PLOS ONE (2012)
MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13
Vijay G. Sankaran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Jian Xu et al.
SCIENCE (2011)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation
Genevieve Galarneau et al.
NATURE GENETICS (2010)
A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction
Ajay Perumbeti et al.
BLOOD (2009)
Dynamics of α-globin locus chromatin structure and gene expression during erythroid differentiation of human CD34+ cells in culture
Milind C. Mahajan et al.
EXPERIMENTAL HEMATOLOGY (2009)
Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin
Tamara I. Pestina et al.
MOLECULAR THERAPY (2009)
Developmental and species-divergent globin switching are driven by BCL11A
Vijay G. Sankaran et al.
NATURE (2009)
DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
Guillaume Lettre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in β-thalassemic mice
Leszek Lisowski et al.
BLOOD (2007)
Sickle cell leg ulcers:: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-β/BMP pathway
VG Nolan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference
S Samakoglu et al.
NATURE BIOTECHNOLOGY (2006)
Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin
M Fragkos et al.
GENE THERAPY (2005)
Correction of a mouse model of sickle cell disease:: lentiviral/antisickling β-globin gene transduction of unmobilized, purified hematopoietic stem cells
DN Levasseur et al.
BLOOD (2003)
Persistent gamma-globin expression in adult transgenic mice is mediated by HPFH-2, HPFH-3, and HPFH-6 breakpoint sequences
EZ Katsantoni et al.
BLOOD (2003)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
